Pain in IBD patients: Very frequent and frequently insufficiently taken into account

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Zeitz, Jonas ^a   Ak, Melike ^a   Muller Mottet, Séverine ^b   Scharl, Sylvie ^a   Biedermann, Luc ^a   Fournier, Nicolas ^c   Frei, Pascal ^d   Pittet, Valerie ^c   Scharl, Michael ^a,e   Fried, Michael ^a   Rogler, Gerhard ^a,e   Vavricka, Stephan ^a,f  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Division of Pulmonology   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d Department of Surgery   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f Division of Gastroenterology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DIPYRONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL;

ABDOMINAL PAIN; ADULT; ARTICLE; BACKACHE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DAILY LIFE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PAIN INTENSITY; PHYSIOTHERAPY; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL BEHAVIOR; ULCERATIVE COLITIS; COMPLICATION; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; TIME FACTOR;

ADULT; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE; TIME FACTORS;

EID: 84976534616     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156666     Document Type: Article

References (49)

1. Wagtmans MJ, Verspaget HW, Lamers CB, Van Hogez and RA. Crohn's disease in the elderly: A comparison with young adults. J Clin Gastroenterol. 1998; 27(2):129-33. PMID: 9754773.
2. Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: A review of 457 cases. J Gastroenterol Hepatol. 2005; 20(11):1691-5. doi: 10.1111/j.1440-1746.2005. 03905.x PMID: 16246187.
3. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996; 23(1):29-34. PMID: 8835896.
4. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study. World journal of gastroenterology: WJG. 2003; 9(10):2300-7. PMID: 14562397; PubMed Central PMCID: PMCPMC4656482.
5. Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflammatory bowel diseases. 2015; 21(8):1982-92. PMID: 26154136; PubMed Central PMCID: PMCPMC4511685.
6. Salvarani C, Vlachonikolis IG, Van Der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, et al. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2001; 36(12):1307-13. PMID: 11761022.
7. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011; 106(1):110-9. doi: 10.1038/ajg.2010.343 PMID: 20808297.
8. Palm O, Bernklev T, Moum B, Gran JT. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. The Journal of rheumatology. 2005; 32(9):1755-9. PMID: 16142874.
9. D'Inca R, Podswiadek M, Ferronato A, Punzi L, Salvagnini M, Sturniolo GC. Articular manifestations in inflammatory bowel disease patients: A prospective study. Dig Liver Dis. 2009; 41(8):565-9. doi: 10. 1016/j.dld.2009.01.013 PMID: 19278908.
10. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study. Am J Gastroenterol. 2001; 96(4):1116-22. doi: 10. 1111/j.1572-0241.2001.03756.x PMID: 11316157.
11. Lanna CC, Ferrari Mde L, Rocha SL, Nascimento E, De Carvalho MA, da Cunha AS. A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: Analysis of articular and ophthalmologic manifestations. Clin Rheumatol. 2008; 27(4):503-9. doi: 10.1007/s10067-007-0797-5 PMID: 18097711.
12. Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatology international. 2006; 26(7):663-8. doi: 10.1007/s00296-005-0044-9 PMID: 16136311.
13. De Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: Prevalence and HLA association. The Journal of rheumatology. 2000; 27(12):2860-5. PMID: 11128677.
14. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history. Gut. 1998; 42(3):387-91. PMID: 9577346; PubMed Central PMCID: PMCPMC1727027.
15. Brynskov J, Binder V. Arthritis and the gut. Eur J Gastroenterol Hepatol. 1999; 11(9):997-9. PMID: 10503836.
16. Van Erp SJ, Brakenhoff LK, Van Gaalen FA, Van Den Berg R, Fidder HH, Verspaget HW, et al. Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study. Journal of Crohn's & colitis. 2015. doi: 10.1093/ecco-jcc/jjv195 PMID: 26512134.
17. Kukreja M, Bryant AS, Clevel and DC, Dabal R, Hingorani N, Kirklin JK. Health-Related Quality of Life in Adult Survivors After the Fontan Operation. Semin Thorac Cardiovasc Surg. 2015; 27(3):299-306. doi: 10.1053/j.semtcvs.2015.08.007 PMID: 26708372.
18. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol. 2001; 96(9):2737-44. doi: 10.1111/j.1572-0241.2001.04133.x PMID: 11569704.
19. Naliboff BD, Kim SE, Bolus R, Bernstein CN, Mayer EA, Chang L. Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: A structural equation modeling analysis. Am J Gastroenterol. 2012; 107(3):451-9. doi: 10.1038/ajg.2011.377 PMID: 22085819; PubMed Central PMCID: PMCPMC3855477.
20. Luo J, Hendryx M, Safford MM, Wallace R, Rossom R, Eaton C, et al. Newly Developed Chronic Conditions and Changes in Health-Related Quality of Life in Postmenopausal Women. J Am Geriatr Soc. 2015; 63(11):2349-57. doi: 10.1111/jgs.13796 PMID: 26503351.
21. Padua L, Aprile I, Frusciante R, Iannaccone E, Rossi M, Renna R, et al. Quality of life and pain in patients with facioscapulohumeral muscular dystrophy. Muscle Nerve. 2009; 40(2):200-5. doi: 10. 1002/mus.21308 PMID: 19609906.
22. Jakobsson U, Hallberg IR. Pain and quality of life among older people with rheumatoid arthritis and/or osteoarthritis: A literature review. J Clin Nurs. 2002; 11(4):430-43. PMID: 12100639.
23. Fujimura T, Takahashi S, Kume H, Takeuchi T, Clinical Study Group of Tokyo University Affiliated H, Kitamura T, et al. Cancer-related pain and quality of life in prostate cancer patients: Assessment using the Functional Assessment of Prostate Cancer Therapy. Int J Urol. 2009; 16(5):522-5. doi: 10.1111/j. 1442-2042.2009.02291.x PMID: 19383037.
24. Ryan JL, Mellon MW, Junger KW, Hente EA, Denson LA, Saeed SA, et al. The clinical utility of healthrelated quality of life screening in a pediatric inflammatory bowel disease clinic. Inflammatory bowel diseases. 2013; 19(12):2666-72. doi: 10.1097/MIB.0b013e3182a82b15 PMID: 24051932; PubMed Central PMCID: PMCPMC3863996.
25. Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, et al. Health-related quality of life in Crohn's disease: A prospective longitudinal study in 231 patients. Am J Gastroenterol. 2001; 96 (10):2915-20. doi: 10.1111/j.1572-0241.2001.4681-b.x PMID: 11693326.
26. Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol. 2001; 13(5):567-72. PMID: 11396538.
27. Irvine EJ. Quality of life in inflammatory bowel disease and other chronic diseases. Sc and J Gastroenterol Suppl. 1996; 221:26-8. PMID: 9110394.
28. Siebert U, Wurm J, Gothe RM, Arvandi M, Vavricka SR, Von Kanel R, et al. Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: Results of the swiss inflammatory bowel disease cohort study. Inflammatory bowel diseases. 2013; 19(4):847-55. doi: 10.1097/MIB. 0b013e31827f278e PMID: 23446333.
29. Schirbel A, Reichert A, Roll S, Baumgart DC, Buning C, Wittig B, et al. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World journal of gastroenterology: WJG. 2010; 16(25):3168-77. PMID: 20593502; PubMed Central PMCID: PMC2896754.
30. Bielefeldt K, Ozaki N, Gebhart GF. Experimental ulcers alter voltage-sensitive sodium currents in rat gastric sensory neurons. Gastroenterology. 2002; 122(2):394-405. PMID: 11832454.
31. Srinath A, Young E, Szigethy E. Pain management in patients with inflammatory bowel disease: Translational approaches from bench to bedside. Inflammatory bowel diseases. 2014; 20(12):2433-49. doi: 10.1097/MIB.0000000000000170 PMID: 25208108.
32. Ananthakrishnan AN, Higuchi LM, Huang ES, Khalili H, Richter JM, Fuchs CS, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: A cohort study. Ann Intern Med. 2012; 156(5):350-9. doi: 10.7326/0003-4819-156-5-201203060-00007 PMID: 22393130; PubMed Central PMCID: PMCPMC3369539.
33. Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS. Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease. J Clin Gastroenterol. 2015. doi: 10. 1097/MCG.0000000000000421 PMID: 26485106.
34. Takeuchi K, Smale S, Premch and P, Maiden L, Sherwood R, Thjodleifsson B, et al. Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clinical gastroenterology and hepatology: The official clinical practice journal of the American Gastroenterological Association. 2006; 4(2):196-202. PMID: 16469680.
35. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993; 104(6):1832-47. PMID: 8500743.
36. Kaufmann HJ, Taubin HL. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med. 1987; 107(4):513-6. PMID: 3498419.
37. Miner PB Jr. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol. 1997; 92(12 Suppl):1S-4S. PMID: 9395345.
38. Kefalakes H, Stylianides TJ, Amanakis G, Kolios G. Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: Myth or reality? European journal of clinical pharmacology. 2009; 65(10):963-70. doi: 10.1007/s00228-009-0719-3 PMID: 19711064.
39. Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflammatory bowel diseases. 2009; 15(5):778-88. doi: 10.1002/ibd.20848 PMID: 19130619; PubMed Central PMCID: PMC3180862.
40. Rath HC, Andus T, Caesar I, Scholmerich J. [Initial symptoms, extra-intestinal manifestations and course of pregnancy in chronic inflammatory bowel diseases]. Med Klin (Munich). 1998; 93(7):395-400. PMID: 9711052.
41. Hazratjee N, Agito M, Lopez R, Lashner B, Rizk MK. Hospital readmissions in patients with inflammatory bowel disease. Am J Gastroenterol. 2013; 108(7):1024-32. doi: 10.1038/ajg.2012.343 PMID: 23820989.
42. Pittet V, Juillerat P, Mottet C, Felley C, Ballabeni P, Burn and B, et al. Cohort profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). International journal of epidemiology. 2009; 38(4):922-31. doi: 10.1093/ije/dyn180 PMID: 18782896.
43. Nagel B, Gerbershagen HU, Lindena G, Pfingsten M. [Development and evaluation of the multidimensional German pain questionnaire]. Schmerz. 2002; 16(4):263-70. doi: 10.1007/s00482-002-0162-1 PMID: 12192435.
44. Heikenen JB, Werlin SL, Brown CW, Balint JP. Presenting symptoms and diagnostic lag in children with inflammatory bowel disease. Inflammatory bowel diseases. 1999; 5(3):158-60. PMID: 10453370.
45. Siegel CA, MacDermott RP. Is chronic pain an extraintestinal manifestation of IBD? Inflammatory bowel diseases. 2009; 15(5):769-71. doi: 10.1002/ibd.20844 PMID: 19107773.
46. Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World journal of gastroenterology: WJG. 2014; 20(46):17463-7. doi: 10.3748/wjg.v20.i46.17463 PMID: 25516659; PubMed Central PMCID: PMCPMC4265606.
47. Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Prinz Vavricka M, Navarini AA, et al. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflammatory bowel diseases. 2015; 21(8):1794-800. doi: 10.1097/MIB.0000000000000429 PMID: 26020601.
48. Van Der Have M, Brakenhoff LK, Van Erp SJ, Kaptein AA, Leenders M, Scharloo M, et al. Back/joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease: A 12-month longitudinal study. Journal of Crohn's & colitis. 2015; 9(3):276-83. doi: 10.1093/ecco-jcc/jju025 PMID: 25547976.
49. Sveaas SH, Berg IJ, Provan SA, Semb AG, Hagen KB, Vollestad N, et al. Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: A randomized controlled pilot study. PloS one. 2014; 9(9):e108688. doi: 10.1371/journal.pone.0108688 PMID: 25268365; PubMed Central PMCID: PMCPMC4182541.